Led by the Miller School’s Robert J. Myerburg, M.D., a dozen experts in sudden cardiac arrest have issued a major report on pulseless electrical activity aimed at improving the dismal survival rate among the increasing number of people who suffer this mechanism of cardiac arrest that does not respond to defibrillation.
Published online in advance of print in Circulation, the official journal of the American Heart Association, the report, “Pulseless Electrical Activity – Definition, Causes, Mechanisms, Management, and Research Priorities for the Next Decade,” summarizes the findings of a June 2012 workshop the National Heart, Lung and Blood Institute convened to identify the current knowledge, scientific gaps and research priorities for predicting, preventing, and managing the condition that has emerged as a more frequent mechanism for sudden cardiac arrest than ventricular fibrillation (VF) or other ventricular tachyarrhythmias (VT).
U Innovation, home of technology advancement at the University of Miami, is celebrating the first initial public offering (IPO) by a company to evolve from its mission to bring life-enhancing discoveries made by UM scientists to the marketplace. The company, Heat Biologics (NASDAQ: HTBX), raised $27 million to fund clinical trials for its proprietary, unique off-the-shelf ImPACT (Immune Pan Antigen Cytotoxic Therapy) vaccines.
Bascom Palmer Eye Institute celebrated its XXXV Annual Inter-American Course in Clinical Ophthalmology (CURSO) at the Intercontinental Miami on November 24-27. The four-day course was a tremendous success with 720 ophthalmologists from more than 30 countries in Latin America and the Caribbean in attendance.
Under the leadership of Omaida C. Velazquez, M.D., the Division of Vascular and Endovascular Surgery is coming of age at the University of Miami Miller School of Medicine.
A delegation of health officials from the Bahamas cut the ribbon for a new helipad at the University of Miami Hospital in a November 25 dedication ceremony that strengthened the Caribbean nation's ties with the Miller School of Medicine and UHealth.
Methamphetamine is a highly addictive stimulant associated with serious health and psychiatric conditions, as well as the transmission of infectious diseases. A group of MIller School researchers has uncovered a method to prevent one of the drug’s primary effects on the brain.